Retrieving...
EP Vantage Interviews
<PARAMS currencyId="0"><PARAM linkKind="0" compId="co_1" all="true" /></PARAMS>
What is this?
Comment & Analysis
Latest
Deals
Regulatory
R&D
Company Strategy
Event - Pradaxa adcom set for wide scrutiny
September 02, 2010
Obesity race tightens up as Takeda snares Contrave
September 02, 2010
Mipomersen reports soaring phase III data but future still up in the air
September 02, 2010
Event - FDA all that stands in AstraZeneca's way on Brilinta
September 01, 2010
Second motavizumab complete response could make AstraZeneca think twice
September 01, 2010
ESC - Eisai and Relypsa contribute good looking mid-stage candidates
August 31, 2010
<PARAMS currencyId="0"><PARAM linkKind="0" compId="co_1" all="true" /></PARAMS>
What is this?
View Archive
EventAnalyzer
Latest
Daily
Weekly
EventAnalyzer
Daily Market Movers (1 Sep 2010)
(September 02, 2010)
Weekly Market Movers (to 27 Aug 2010)
(August 30, 2010)
<PARAMS currencyId="0"><PARAM linkKind="0" compId="co_1" all="true" /></PARAMS>
What is this?
View Archive
Market Moving Events
<PARAMS currencyId="0"><PARAM linkKind="0" compId="co_1" all="true" /></PARAMS>
What is this?
Therapeutic Focus
Latest
Oncology
Cardio
Anti-infectives
CNS
Therapeutic focus - Will hopes evaporate as gene therapy pipeline flows?
(August 25, 2010)
Therapeutic focus - What are plan B options if A-beta Alzheimer's hypothesis is void?
(August 19, 2010)
Therapeutic focus - Vectibix failure leaves few new options for head and neck cancer
(August 16, 2010)
Therapeutic focus - Anti-infectives market shrinking as new superbug fears emerge
(August 11, 2010)
more...
<PARAMS currencyId="0"><PARAM linkKind="0" compId="co_1" all="true" /></PARAMS>
What is this?
Retrieving Data
Email this page to a colleague